Molecular Evaluation of Resistance to Rifampicin and Isoniazid of Tuberculosis Patients by test “Genotype® MTBDR Plus” in Senegal

Research Article - (2018) Volume 6, Issue 5

Babacar Faye^1,^2,³^*, Issa Jessika¹, Mame Cheikh Seck^1,⁴, Cheikh Tidiane Ndour⁵, Papa Amadou Lamine Gueye⁶, Fatoumata Ba⁶, Marie Sarr⁶, Michael Grillo⁷, Sharon Reed⁸ and Alioune Dieye³: ¹Laboratory of Molecular Biology, Military Hospital of Ouakam (HMO), Dakar, Senegal; ²AIDS Program of the Senegalese Armed Forces, Senegal; ³Service of Immunology, Department of Pharmacy, Faculty of Medicine, Pharmacy and Odonto- Stomatology, Cheikh Anta Diop University, Dakar, Senegal; ⁴Parasitology Unit, Department of Pharmacy, Faculty of Medicine, Pharmacy and Odonto-Stomatology, Cheikh Anta Diop University, Dakar, Senegal; ⁵Service des Maladies Infectieuses Centre National Hospitalier de FANN, Dakar, Senegal; ⁶National Program against Tuberculosis (NTP) in Senegal, Senegal; ⁷Department of Defense HIV/AIDS Prevention Program (DHAPP), San Diego, California, United States; ⁸Microbiology and Virology Laboratories, University of California, San Diego Center, United States

^*Corresponding Author: